ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,201Medicare Part D Prescriptions Filled, Including Refills

Rank: 1522 out of 5254

$374K Total Retail Price of All Prescriptions

Rank: 2150 out of 5254

177 Patients Receiving at Least One Drug in Part D
81% Patients 65 Years and Older
97% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in New York
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

15% of this provider’s 177 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

N/A

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $71 among peers.

Prescriptions per Patient

41 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in New York
AMLODIPINE BESYLATE 301 227 42 1 2
WARFARIN SODIUM 288 283* 26 2 13
QUETIAPINE FUMARATE 287 234 40 A 3 62
METOPROLOL TARTRATE 259 229 47 4 9
SANTYL 213 171 21 5 148
LISINOPRIL 160 143 23 6 6
NYSTATIN 153 136 37 7 137
RANITIDINE HCL 146 129 28 8 41
MIRTAZAPINE 143 119 28 9 44
SIMVASTATIN 139 127 32 10 1
OMEPRAZOLE 121 95 30 11 5
CITALOPRAM HBR 116 105 22 12 36
FUROSEMIDE 105 76 24 13 8
LEVETIRACETAM 102 88 16 14 91
LEVOTHYROXINE SODIUM 102 87 15 14 4
ATORVASTATIN CALCIUM 95 76 14 16 3
SERTRALINE HCL 94 <11 <11 17 27
TAMSULOSIN HCL 84 79* 15 18 19
NOVOLOG FLEXPEN 83 61 31 19 160
NYSTATIN-TRIAMCINOLONE 79 57 13 20 198
METFORMIN HCL 76 71* 12 21 7
SSD 76 52 14 21 214
CLOPIDOGREL 74 62 13 23 15
LACTULOSE 74 69* 23 23 90
IPRATROPIUM BROMIDE 71 66* 28 25 142
CARBIDOPA-LEVODOPA 69 <11 <11 26 106
ENALAPRIL MALEATE 65 53 15 27 24
ALBUTEROL SULFATE 64 59* 31 28 103
BACLOFEN 64 52 11 28 151
LABETALOL HCL 58 <11 <11 30 111
MUPIROCIN* 57 <11 <11 31 192
VALPROIC ACID* 57 52* 11 31 222
LEVEMIR FLEXPEN 53 <11 <11 33 150
LATANOPROST 53 48* 11 33 141
GABAPENTIN 52 47* 14 35 20
SODIUM CHLORIDE* 50 33 11 36 382
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 24, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.